Rondo Therapeutics Doses First Patient in Phase 1 Trial of RNDO-564, a First-in-Class Co-Stimulatory Bispecific Antibody Targeting Nectin-4 in Advanced Solid Tumors Novel CD28 x Nectin-4 bispecific ...
Roche has dropped five Chugai candidates from its clinical pipeline, echoing actions the Japanese business took earlier this year. Chugai revealed (PDF) the suspension of in-house development of the ...
World's biggest X-ray laser discovers never-before-seen type of ice that's solid at room temperature
Researchers have unveiled ice XXI, a new form of ice that's solid at room temperatures when subjected to immense pressure. When you purchase through links on our site, we may earn an affiliate ...
First presentation of clinical data from the sixth DXd antibody drug conjugate from the oncology pipeline of Daiichi Sankyo Early results support continued development of DS-3939, a potential first-in ...
A new analysis method for detecting bisphenols in environmental sources was tested using loofah sponges and solid-phase extraction. Bisphenols (BPs) are synthetic antioxidants that can negatively ...
Y-mAbs announces positive Phase 1 Trial 1001 results for GD2-SADA in cancer, plans further studies with optimized radiohapten "Proteus." Y-mAbs Therapeutics, Inc. announced positive results from the ...
–Favorable safety and tolerability, with promising early activity of novel mRNA-based therapy observed from interim data– BOSTON--(BUSINESS WIRE)--Strand Therapeutics, a leader in next-generation mRNA ...
Sample preparation is essential when employing chromatography for bioanalytical analysis as system performance will be negatively affected if it is not performed. Preparation methods include protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback